home All News open_in_new Full Article

BioVaxys Technology Corp. Closes Listed Issuer Financing Exemption (LIFE) Private Placement

// NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES // VANCOUVER, British Columbia — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (“BioVaxys” or the “Company”) announces that it has closed its previously announced non-brokered private placement financing (the “Offering”) of 11,311,676 units of the Company (the “Units”) at […]


today 2 w. ago attach_file Other

attach_file Economics
attach_file Events
attach_file Economics
attach_file Economics
attach_file Economics
attach_file Economics
attach_file Economics
attach_file Other
attach_file Other
attach_file Other
attach_file Culture
attach_file Economics
attach_file Sport
attach_file Other
attach_file Economics
attach_file Other
attach_file Economics
attach_file Economics
attach_file Other
attach_file Economics


ID: 1707568642
Add Watch Country

arrow_drop_down